Arun Jesudian, MD, moderates an expert panel on hepatic encephalopathy (HE), discussing treatment goals, first-line pharmacotherapy, and the crucial role of medication adherence in preventing relapse among HE patients.
EP. 1: Identifying and Screening for Hepatic Encephalopathy Risk Factors
April 16th 2024Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, delve into the complexities of hepatic encephalopathy, exploring the various risk factors that contribute to its development, such as alcohol-induced cirrhosis, sarcopenia, CNS medications, opioids, and other potential triggers.
Watch
EP. 2: Achieving Post-Discharge Success: Goals in Hepatic Encephalopathy Care
April 16th 2024Medical experts examine the current treatment landscape and goals for patients with hepatic encephalopathy, addressing patient outcomes and hospital discharge planning, while also acknowledging that some patients may require rehabilitation or long-term care facilities to sustain remission and optimize their recovery.
Watch
EP. 4: Addressing the Caregiver Burden in Hepatic Encephalopathy Management
April 23rd 2024Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, highlight the importance of adhering to evidence-based guidelines and utilizing approved medications in the management of hepatic encephalopathy, emphasizing their crucial role in preventing patient relapse within 30 days of hospital discharge.
Watch
EP. 5: Optimizing Care for Newly Diagnosed Hepatic Encephalopathy
April 30th 2024Medical experts discuss the challenges of starting treatment for newly diagnosed, cognitively impaired patients, addressing prescription processes, patient education, and the role of cost, care quality, and convenience in promoting successful medication adherence.
Watch
EP. 6: Enhancing Hepatic Encephalopathy Care through Pharmacist-Prescriber Collaboration
April 30th 2024KOLs emphasize the crucial role of collaboration between pharmacists and physicians in managing hepatic encephalopathy, stressing the importance of monitoring sedating medications, polypharmacy, and patient response to HE therapy, while making necessary adjustments to optimize care.
Watch
EP. 7: Managing Adverse Events Associated with HE Therapies
May 7th 2024Ralph J. Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.
Watch
EP. 8: Integrating Treatment Protocols and Community Pharmacy in HE Management
May 7th 2024Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, highlight the crucial role of pharmacies in providing unbiased patient education. They also emphasize the significance of incorporating treatment protocols into medical health records and utilizing various tools to optimize the success of hepatic encephalopathy treatment.
Watch